GO
Loading...

Biogen Idec Inc

More

  • Final Glance: Biotechnology companies Monday, 20 Oct 2014 | 6:05 PM ET

    Amgen Inc. rose $3.82 or 2.9 percent, to $137.51. Biogen Idec rose $4.70 or 1.5 percent, to $311.41. Celgene Corp. rose $3.88 or 4.4 percent, to $92.00.

  • Midday Glance: Biotechnology companies Monday, 20 Oct 2014 | 1:23 PM ET

    Amgen Inc. rose$. 35 or. 3 percent, to $134.04. Biogen Idec rose $3.41 or 1.1 percent, to $310.12. Celgene Corp. rose $3.24 or 3.7 percent, to $91.36.

  • Early Glance: Biotechnology companies Monday, 20 Oct 2014 | 10:40 AM ET

    Amgen Inc. rose$. 93 or. 7 percent, to $134.62. Biogen Idec rose $2.07 or. 7 percent, to $308.78. Celgene Corp. rose $1.72 or 2.0 percent, to $89.84.

  • Final Glance: Biotechnology companies Friday, 17 Oct 2014 | 6:03 PM ET

    Amgen Inc. rose $3.24 or 2.5 percent, to $133.69. Biogen Idec rose $3.97 or 1.3 percent, to $306.71. Celgene Corp. rose $1.74 or 2.0 percent, to $88.12.

  • Midday Glance: Biotechnology companies Friday, 17 Oct 2014 | 1:21 PM ET

    Amgen Inc. rose $3.30 or 2.5 percent, to $133.75. Biogen Idec rose $9.17 or 3.0 percent, to $311.91. Celgene Corp. rose $3.04 or 3.5 percent, to $89.42.

  • Early Glance: Biotechnology companies Friday, 17 Oct 2014 | 10:39 AM ET

    Amgen Inc. rose$. 25 or. 2 percent, to $130.70. Biogen Idec rose $8.00 or 2.6 percent, to $310.74. Celgene Corp. rose $2.45 or 2.8 percent, to $88.83.

  • Final Glance: Biotechnology companies Thursday, 16 Oct 2014 | 6:02 PM ET

    Amgen Inc. fell$. 45 or. 3 percent, to $130.45. Biogen Idec fell $2.95 or 1.0 percent, to $302.74. Celgene Corp. fell$. 17 or. 2 percent, to $86.38.

  • Midday Glance: Biotechnology companies Thursday, 16 Oct 2014 | 1:21 PM ET

    Amgen Inc. fell $1.85 or 1.4 percent, to $129.05. Biogen Idec fell $2.23 or. 7 percent, to $303.46. Celgene Corp. fell$. 18 or. 2 percent, to $86.37.

  • Early Glance: Biotechnology companies Thursday, 16 Oct 2014 | 11:35 AM ET

    Amgen Inc. fell $1.81 or 1.4 percent, to $129.09. Biogen Idec fell $2.69 or. 9 percent, to $303.00. Celgene Corp. fell $1.56 or 1.8 percent, to $84.99.

  • Oct 16- Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow. The company, whose profit topped expectations for the fourth straight quarter, cut its 2014 earnings forecast to $4.86- $4.89 per share to exclude gains from its vaccine business that it...

  • Final Glance: Biotechnology companies Wednesday, 15 Oct 2014 | 6:07 PM ET

    Amgen Inc. fell $1.30 or 1.0 percent, to $130.90. Biogen Idec rose $4.11 or 1.4 percent, to $305.69. Celgene Corp. rose$. 07 or. 1 percent, to $86.55.

  • The first, Esbriet, was developed by InterMune Inc, which Switzerland- based Roche Holding AG agreed to buy for $8.3 billion in August, banking largely on the treatment's potential. The agency's decision marks a crucial milestone in the management of the disease, which affects about 100,000 people in the United States. Roche's drug, known generically as...

  • Midday Glance: Biotechnology companies Wednesday, 15 Oct 2014 | 1:17 PM ET

    Amgen Inc. fell $2.15 or 1.6 percent, to $130.05. Biogen Idec rose $5.29 or 1.8 percent, to $306.87. Celgene Corp. fell $1.36 or 1.6 percent, to $85.12.

  • *Shire shares tumble as AbbVie reconsiders bid. NEW YORK, Oct 15- U.S. stocks dropped on Wednesday as economic data buttressed worries over the health of the world economy and signs emerged of slowing merger activity. Worries about a lethargic global economy weren't helped by data that showed U.S. retail sales and producer prices fell in September, while...

  • Early Glance: Biotechnology companies Wednesday, 15 Oct 2014 | 10:46 AM ET

    Amgen Inc. fell $1.56 or 1.2 percent, to $130.64. Biogen Idec rose $1.69 or. 6 percent, to $303.27. Celgene Corp. fell$. 90 or 1.0 percent, to $85.58.

  • Final Glance: Biotechnology companies Tuesday, 14 Oct 2014 | 6:03 PM ET

    Amgen Inc. fell $1.36 or 1.0 percent, to $132.20. Biogen Idec fell$. 16 or. 1 percent, to $301.58. Celgene Corp. fell $1.00 or 1.1 percent, to $86.48.

  • Midday Glance: Biotechnology companies Tuesday, 14 Oct 2014 | 1:42 PM ET

    Amgen Inc. fell$. 09 or. 1 percent, to $133.47. Biogen Idec rose $3.62 or 1.2 percent, to $305.36. Celgene Corp. rose$. 66 or. 8 percent, to $88.14.

  • Early Glance: Biotechnology companies Tuesday, 14 Oct 2014 | 10:27 AM ET

    Amgen Inc. fell$. 92 or. 7 percent, to $132.64. Biogen Idec fell $5.23 or 1.7 percent, to $296.51. Celgene Corp. fell $1.41 or 1.6 percent, to $86.07.

  • Midday Glance: Biotechnology companies Monday, 13 Oct 2014 | 1:19 PM ET

    Amgen Inc. fell $1.25 or. 9 percent, to $136.14. Biogen Idec fell $3.26 or 1.0 percent, to $311.88. Celgene Corp. fell $1.31 or 1.4 percent, to $89.62.

  • Early Glance: Biotechnology companies Monday, 13 Oct 2014 | 10:29 AM ET

    Amgen Inc. fell$. 88 or. 6 percent, to $136.51. Biogen Idec fell $5.01 or 1.6 percent, to $310.13. Celgene Corp. fell $1.50 or 1.6 percent, to $89.43.